Smart Rings Could Passively Monitor Patients With Chronic Disease Worldwide

Digital health tools have proliferated rapidly, yet a persistent problem undermines their utility in long-term studies: patient adherence wanes over time, especially when multiple devices require active engagement. This viewpoint paper from researchers affiliated with Novartis and Tufts University Medical Center argues that smart ring technology represents a compelling solution—a near-minimal wearable form factor capable of hosting multiple sensors while imposing minimal burden on the user.

The authors outline a hub-and-spoke architecture where smart rings continuously collect physiological data—photoplethysmography, temperature, heart rate variability, and actigraphy—and transmit it passively to cloud-based electronic health records. Connectivity options range from Bluetooth to smartphones, Wi-Fi on local area networks, LoRaWAN for infrastructure-limited regions, and emerging low-orbit satellite systems such as Starlink. This layered approach would theoretically enable continuous passive monitoring anywhere on the planet, making the technology viable for both clinical trials and population-level surveillance in low- and middle-income countries.

The most compelling use cases identified are longitudinal monitoring of slow-progressing diseases such as cardiovascular and neurodegenerative conditions, where traditional episodic clinical assessments miss important real-world fluctuations. The authors also envision emergency alert systems tied to GSM location tracking, pandemic mobility monitoring, and integration with national electronic health record systems. Emerging prototype sensors—including galvanic skin monitors, nano-tattoo circuits, and custom analyte cells—could further expand the ring's diagnostic scope.

Several significant obstacles are candidly acknowledged. Achieving clinical-grade sensor accuracy remains a long-term objective, as current consumer smart rings do not meet medical-device standards. Power supply constraints require advances in battery technology, solar harvesting, and kinetic energy capture. Regulatory compliance across jurisdictions (FDA, EMA, HIPAA, GDPR) is complex and will evolve alongside the technology. The authors also address funding models, proposing philanthropic investment, nation-state sponsorship offsetting downstream healthcare savings, and the tokenization of anonymized personal health data as potential revenue streams.

The paper concludes with a call to action for the device engineering community, health technology advocates, and global health organizations to accelerate dialogue and collaboration. While this is a conceptual viewpoint rather than an empirical study, it provides a structured framework for the next generation of passive remote monitoring infrastructure—one that could meaningfully transform chronic disease management and global health surveillance.